CytoDyn received first order from Chiral Pharma for use of Leronlimab for COVID-19 patients in the Philippines
On Jun. 1, 2021, CytoDyn announced that Chiral Pharma in the Philippines placed its first purchase order for leronlimab under a Compassionate Special Permit to treat critically ill COVID-19 patients in the Philippines.
Tags:
Source: GlobalNewswire
Credit:
